COMMUNIQUÉS West-GlobeNewswire

-
Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
01/02/2024 -
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
01/02/2024 -
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/02/2024 -
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
01/02/2024 -
Revolution Medicines to Participate in Upcoming Investor Conferences
01/02/2024 -
Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader
01/02/2024 -
NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01/02/2024 -
TCG Labs-Soleil Raises Inaugural Fund of Over $400 Million
01/02/2024 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
01/02/2024 -
SweetWater Brewing and Pullman Yards Present 420 Fest on April 20 & 21, 2024
01/02/2024 -
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET
01/02/2024 -
Crossject organisera un webcast le 6 février à 17h30 pour faire le point sur sa stratégie commerciale
01/02/2024 -
EssilorLuxottica: Full-Year 2023 Results Conference Call Invitation
01/02/2024 -
Number of votings rights as of January 31 2024
01/02/2024 -
Nombre de droits de vote au 31 janvier 2024
01/02/2024 -
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
01/02/2024 -
Alira Health Releases Global Report on Robotic-Assisted Surgery (RAS) in Orthopedic Procedures
01/02/2024 -
Enlitic® Announces Appointment of Steve Rankin as Chief Strategy Officer
01/02/2024 -
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
01/02/2024
Pages